Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ARTEMETHER\LUMEFANTRINE vs ASCIMINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ARTEMETHER\LUMEFANTRINE vs ASCIMINIB: Safety Overview

Metric ARTEMETHER\LUMEFANTRINE ASCIMINIB
Total FAERS Reports 291 2,330
Deaths Reported 14 269
Death Rate 4.8% 11.5%
Hospitalizations 140 426
Average Patient Age 33.5 yrs 61.2 yrs
% Female Patients 50.0% 50.5%
FDA Approval Date N/A Apr 18, 2024
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription